Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Oral Cavity & Pharynx (Late Stage^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Count
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count ascending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 7.4 (7.4, 7.5) N/A 29,248 62.9
California 3 6.5 (6.4, 6.6) 44 (40, 46) 2,929 64.5
Florida 6 8.4 (8.2, 8.5) 9 (5, 16) 2,509 60.1
Texas 3 6.7 (6.6, 6.9) 40 (36, 44) 2,048 60.6
New York 3 7.2 (7.0, 7.3) 33 (27, 38) 1,775 64.0
Pennsylvania 6 8.0 (7.8, 8.2) 16 (11, 24) 1,372 64.3
Ohio 6 8.4 (8.2, 8.6) 10 (4, 17) 1,268 67.2
Illinois 3 7.8 (7.6, 8.0) 20 (14, 28) 1,222 64.6
North Carolina 6 8.2 (7.9, 8.4) 14 (6, 22) 1,066 65.6
Georgia 3 8.4 (8.2, 8.7) 8 (3, 16) 1,029 68.0
Michigan 6 7.6 (7.4, 7.9) 23 (17, 31) 995 64.9
New Jersey 3 7.2 (6.9, 7.4) 34 (25, 39) 822 63.4
Virginia 6 7.0 (6.8, 7.2) 37 (28, 41) 735 61.9
Tennessee 6 8.2 (7.9, 8.4) 15 (6, 23) 700 63.5
Massachusetts 3 7.8 (7.5, 8.1) 21 (13, 30) 693 67.5
Missouri 6 8.7 (8.4, 9.0) 5 (2, 14) 677 67.5
Washington 5 7.3 (7.1, 7.6) 31 (22, 37) 670 59.7
Wisconsin 6 7.9 (7.6, 8.2) 17 (9, 28) 608 63.8
South Carolina 6 8.3 (7.9, 8.6) 13 (4, 22) 556 66.5
Maryland 6 6.9 (6.6, 7.1) 39 (30, 44) 517 62.5
Kentucky 3 9.0 (8.7, 9.4) 2 (1, 8) 513 67.4
Louisiana 3 8.6 (8.2, 8.9) 7 (2, 17) 485 66.2
Arizona 6 5.3 (5.0, 5.5) 49 (46, 49) 478 58.6
Minnesota 6 6.6 (6.4, 6.9) 41 (34, 46) 463 53.2
Colorado 6 6.6 (6.3, 6.9) 42 (35, 46) 436 62.0
Oregon 6 7.9 (7.5, 8.2) 19 (9, 30) 430 65.5
Alabama 6 6.5 (6.3, 6.8) 43 (36, 46) 412 52.7
Connecticut 3 7.5 (7.1, 7.8) 27 (16, 37) 360 62.8
Oklahoma 6 7.5 (7.2, 7.9) 26 (15, 37) 353 57.7
Iowa 3 8.3 (7.9, 8.8) 11 (3, 23) 332 59.2
Arkansas 6 8.8 (8.3, 9.2) 4 (2, 15) 330 63.7
Mississippi 6 8.3 (7.9, 8.7) 12 (3, 25) 306 64.0
Kansas 6 7.1 (6.7, 7.5) 35 (22, 43) 249 60.9
West Virginia 6 9.9 (9.3, 10.5) 1 (1, 3) 249 69.5
Maine 6 9.0 (8.4, 9.6) 3 (1, 16) 179 64.8
Puerto Rico 6 4.2 (3.9, 4.5) N/A 175 47.6
Nebraska 6 7.5 (7.0, 8.0) 28 (13, 40) 170 58.2
Utah 3 5.4 (5.0, 5.8) 48 (45, 49) 155 56.9
Idaho 3 7.0 (6.5, 7.5) 38 (21, 46) 151 58.1
New Mexico 3 5.6 (5.2, 6.1) 47 (45, 49) 150 62.0
New Hampshire 6 7.6 (7.0, 8.2) 24 (7, 39) 147 63.3
Hawaii 3 7.9 (7.3, 8.5) 18 (4, 36) 144 61.4
Montana 6 7.6 (6.9, 8.3) 25 (6, 43) 108 63.4
Rhode Island 6 7.4 (6.7, 8.1) 30 (9, 45) 105 67.3
Delaware 6 7.5 (6.8, 8.2) 29 (7, 44) 99 63.9
South Dakota 6 7.0 (6.3, 7.8) 36 (14, 46) 75 57.2
Vermont 6 8.6 (7.7, 9.6) 6 (1, 31) 75 68.9
North Dakota 6 7.2 (6.4, 8.1) 32 (7, 46) 64 55.9
Alaska 6 7.6 (6.8, 8.6) 22 (3, 45) 62 65.0
Wyoming 6 6.1 (5.3, 7.0) 46 (27, 49) 44 56.6
District of Columbia 6 6.3 (5.4, 7.2) 45 (25, 49) 44 61.8
Indiana 6
data not available
N/A
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 05/22/2024 8:05 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top